The decision to suspend the trial is viewed as highly questionable, raising disturbing questions about the role that marketing played–especially in light of the fact that Zytiga’s patent is due to expire in 2017. 

Read More

The latest area of controversy focuses on the proposed revision of the definition "behavioral addiction disorder" extending the addiction diagnosis to include drug, alcohol and gambling.  It is estimated that the change would expand the number of people labeled as "addicts" by 20 to 30 million who would be entitled to treatment and disability payments costing taxpayers many hundreds of millions of dollars.

Read More

At a minimum, the practice of responsible medicine requires that physicians who prescribe drugs whose  known severe adverse side effects are likely to cause their patients irreversible harm, requires that those physicians follow monitoring guidelines to ensure their patients’ safety. 

Read More
nyt_syphilis-news_clip_1947.jpg

  A year after professor Susan M. Reverby, a historian at Wellesley College in Massachusetts, uncovered a heinous Guatemalan syphilis experiment conducted between 1946 and 1948, on at least 5,500 under the auspices of the US Public Health Service, a hearing was held this week about the findings of the President’s Bioethics Commission investigation. The…

Read More

Three new studies–one,, a pharmaco-genetic study, is groundbreaking–confirm that widely prescribed psychotropic drugs that pose serious risks of harm, offer no therapeutic benefit.

 

Read More

Before 2007,  the research community had dogmatically insisted that only embryonic stem cell research would be medically useful, and that adult stem cell research was a waste of resources and effort.  The contentious debate was framed as between “enlightened” scientists and religious fundamentalists. Like many dogmatic theoretical constructs–this one proved to be false. The Institute…

Read More